Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Taro Pharmaceuticals USA"
Count: 69
Selected: 0
| NCT ID | Title |
|---|
| NCT03645499 | An Open-Label Study to Assess Safety | ||
| NCT05282771 | A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and Tazarotene Lotion), 0.01%/0.045% (Reference Listed Drug) in the Treatment of Moderate to Severe Plaque Psoriasis. | ||
| NCT05148689 | A Study Comparing Oxymetazoline 1% Cream to RHOFADE | ||
| NCT04883736 | A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne Vulgaris | ||
| NCT04883593 | A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis. | ||
| NCT04797793 | A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris | ||
| NCT04724473 | A Study Comparing Tretinoin Cream 0.025% and RETIN-A® Cream 0.025% in the Treatment of Acne Vulgaris | ||
| NCT04358770 | Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream | ||
| NCT02340169 | Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis | ||
| NCT04321070 | Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris | ||
| NCT04134273 | Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris | ||
| NCT01876550 | A Study to Evaluate the Safety and Bioequivalence of Mupirocin Calcium Cream, 2% and Bactroban® Cream and Compare Both to a Vehicle in Treatment of Secondarily Infected Traumatic Skin Lesions. | ||
| NCT03880357 | To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis | ||
| NCT03689010 | To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea | ||
| NCT02933879 | Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study | ||
| NCT02933502 | Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product | ||
| NCT02618759 | Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis | ||
| NCT02932891 | An Open Label, Safety Study to Assess the Potential for Adrenal Suppression. | ||
| NCT02601469 | Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Plaque Psoriasis | ||
| NCT02595073 | Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis | ||
| NCT02595008 | Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic Dermatitis | ||
| NCT02933866 | Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis | ||
| NCT02933528 | Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS | ||
| NCT02932878 | An Open Label, Safety Study to Assess the Potential for Adrenal Suppression | ||
| NCT02932462 | Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis | ||
| NCT02413229 | A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study | ||
| NCT02935036 | Efficacy Study in Patients With Acne Vulgaris. | ||
| NCT02343627 | Safety and Efficacy of NVXT Solution in Mild-to-Moderate Fungal Infection of the Toe Nail | ||
| NCT02335255 | Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis | ||
| NCT03433378 | To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris | ||
| NCT03427554 | To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne Vulgaris | ||
| NCT03257943 | A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5% | ||
| NCT02578043 | A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris | ||
| NCT01206387 | Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis | ||
| NCT02132260 | Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea Pedis | ||
| NCT01769235 | Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris | ||
| NCT01580878 | Evaluate the Safety & Bioequivalence of a Generic Butenafine Cream & Lotrimin Ultra® & Compare Both to a Vehicle Control in Treatment of Interdigital Tinea Pedis | ||
| NCT03132194 | Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris | ||
| NCT03094403 | To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel | ||
| NCT02929719 | Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris | ||
| NCT02709902 | Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris | ||
| NCT02595034 | A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris | ||
| NCT02411955 | A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris | ||
| NCT02411942 | Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris | ||
| NCT01742637 | Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris | ||
| NCT00752973 | Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice | ||
| NCT01018134 | Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study | ||
| NCT00927472 | Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice | ||
| NCT01206660 | Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis | ||
| NCT00963508 | Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice |
